RE:In the meantime, Genting is moving up
A few weeks later Genting shares have started moving up again. Closed at 4.90myr today in Malaysia.
Speculation. It is all speculation!
From a discussion board in Malaysia today:
"In addition, Genting has call options in TauRx Pharmaceuticals Ltd, in which it holds 20% of the shares, which is currently developing drugs to treat Alzheimer's disease.
It is understood that TauRx has submitted its lead drug hydrogen methylthionine methanesulfonate (HMTM) to the UK Medicines and Healthcare Products Regulatory Agency for consideration for approval.
"We currently value TauRx at only US$1 billion (RM4.65 billion). If the company's valuation reaches US$15 billion as previously reported, our target price for Genting may be raised to more than RM8."
Maybank Investment Bank maintained its "buy" rating on Genting and raised its target price to RM5.84 from RM5.49."